Back to Results
First PageMeta Content
Medicine / Health / Drug safety / Pharmaceuticals policy / Food safety / Good manufacturing practice / New Drug Application / Investigational New Drug / Pharmaceutical industry / Pharmaceutical sciences / Food and Drug Administration


Consent Decree of Permanent Injunction: KV Pharmaceutical
Add to Reading List

Open Document

File Size: 460,24 KB

Share Result on Facebook

City

St. Louis / /

Company

KV PHARMACEUTICAL COMPANY / ETHEX CORPORATION / 29 KV Pharmaceutical / THER-RX CORPORATION / /

Country

United States / /

Event

FDA Phase / /

Facility

KV facility / /

IndustryTerm

drug manufacturing facilities / internet site information / certification protocol / manufacturing / manufacturing practice / manufacturing process design procedures / drug products / batch certification protocol / drug manufacturing processes / /

MedicalTreatment

dietary supplement / /

Organization

Defendants' Quality Control Unit / United States Food and Drug Administration / /

Person

RITA E. BLESER / JAY S. SAWARDEKER / MARC S. HERMELIN / DAVID A. VAN VLIET / /

Position

Interim Chief Executive Officer / Vice President / Corporate Quality Assurance/Quality Control / President / Chief Executive Officer / member of the Board of Directors / /

Product

such drug / /

ProvinceOrState

Missouri / /

Technology

batch certification protocol / certification protocol / /

SocialTag